<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.

Neural Connections Blog

MD Biosciences insights discussing preclinical research in Pain and Neurodegenerative Conditions

preclinical drug development

Importance of Diversity in Preclinical Stroke Models

The Need for Diversity in Animal Models The clinical population is diverse, including both sexes, older individuals, and those with comorbid...

Read More

Why are potential pain therapies getting lost in translation?

It is estimated that 1.5 billion people worldwide suffer from Chronic pain. While research has seen tremendous advances in our understanding of pain...

Read More
preclinical drug development

3 ways to improve clinical relevance of preclinical CNS data

The success rate from first candidate to market launch is less than 1%, requiring approximately 22 hits for every drug launched. Within...

Read More